On this page:Overview Publications Researchers Key papers Journals Open access Institutions

ScholarIQanswers from OpenAlex

Pharmaceutical Practices and Patient Outcomes

TopicLeading institutions, researchers & key papers

Pharmaceutical Practices and Patient Outcomes is a topic indexed in ScholarIQ from OpenAlex.

What is known about Pharmaceutical Practices and Patient Outcomes?

ScholarIQrecord summary

This cluster of papers focuses on the challenges and consequences of polypharmacy, inappropriate medication use, and adverse drug events in the elderly population. It explores topics such as potentially inappropriate prescribing, pharmacist interventions, medication reconciliation, deprescribing, and the impact of anticholinergic burden. The research aims to address the complexities of medication management in older adults and improve patient outcomes.

How many works does Pharmaceutical Practices and Patient Outcomes have?

ScholarIQindexed works

Pharmaceutical Practices and Patient Outcomes has 374 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for Pharmaceutical Practices and Patient Outcomes →

What is the OpenAlex record for Pharmaceutical Practices and Patient Outcomes?

ScholarIQopenalex

The OpenAlex for Pharmaceutical Practices and Patient Outcomes is on the source record.

Open the OpenAlex →

What are the most-cited papers on Pharmaceutical Practices and Patient Outcomes?

ScholarIQmost cited works

STOPP/START criteria for potentially inappropriate prescribing in older people: version 3

Denis O’Mahony, Antonio Cherubini, Anna Renom‐Guiteras, Michael Denkinger, Jean‐Baptiste Beuscart, Graziano Onder, Aðalsteinn Guðmundsson, Alfonso J. Cruz‐Jentoft, Wilma Knol, Gülistan Bahat, Nathalie van der Velde, Mirko Petrović, Denis Curtin

European Geriatric Medicine. 2023703 CitationsOPEN ACCESS

Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study

Chris Fox, Kathryn Richardson, Ian Maidment, George M. Savva, Fiona E. Matthews, David Smithard, Simon Coulton, Cornelius Katona, Malaz Boustani, Carol Brayne

Journal of the American Geriatrics Society. 2011646 CitationsOPEN ACCESS

Anticholinergic Drug Exposure and the Risk of Dementia

Carol Coupland, Trevor Hill, Tom Dening, Richard Morriss, Michael Moore, Julia Hippisley‐Cox

JAMA Internal Medicine. 2019599 CitationsOPEN ACCESS

Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.

Mark H. Beers, Joseph G. Ouslander, I Rollingher, David B. Reuben, Jacqueline Brooks, John Beck

PubMed. 1991587 Citations

Polypharmacy and Prescribing Quality in Older People

Michael A. Steinman, C. Seth Landefeld, Gary E. Rosenthal, Daniel Berthenthal, Śaunak Sen, Peter J. Kaboli

Journal of the American Geriatrics Society. 2006539 Citations

Where is Pharmaceutical Practices and Patient Outcomes research published, and who funds it?

ScholarIQvenues & funding sources

TOP JOURNALS

Journal of the American Geriatrics Society1,683

JAMA Internal Medicine965

European Geriatric Medicine703

PubMed587

Health Policy467

TOP FUNDERS

National Science Foundation—

NIH—

Wellcome Trust—

European Research Council—

Funder breakdown is a member featureSign up free to unlock

How much of the research on Pharmaceutical Practices and Patient Outcomes is open access?

ScholarIQopen access share

73%OPEN ACCESS

Gold

Green

27%

Hybrid

13%

Bronze

27%

Closed

27%